Cognitive Therapy Versus Fluoxetine in Generalized Social Phobia: A Randomized Placebo-Controlled Trial

Journal of Consulting and Clinical Psychology

Volumn 71, Issue 6, 2003, Pages 1058-1067

  Clark, David M ^a   Ehlers, Anke ^a   McManus, Freda ^a,c   Hackmann, Ann ^b   Fennell, Melanie ^b   Campbell, Helen ^b,d   Flower, Teresa ^b,e   Davenport, Clare ^b,f   Louis, Beverley ^b,g  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WARNEFORD HOSPITAL   (United Kingdom)

^d BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^e Adolescent Forensic Health Service   (Australia)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NORFLUOXETINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; EXPOSURE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENTAL DISEASE; OUTCOMES RESEARCH; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SELF EXPOSURE; SOCIAL PHOBIA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DESENSITIZATION, PSYCHOLOGIC; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; PHOBIC DISORDERS; RETREATMENT; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0344926508     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.71.6.1058     Document Type: Article

References (64)

1. Allgulander, C. (1999). Paroxetine in social anxiety disorder: A randomized placebo-controlled study. Acta Psychiatrica Scandinavica. 100, 193-198.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington DC: Author.
3. Baker, S. L., Heinrichs, N., Kim, H-J., & Hofman, S. G. (2002). The Liebowitz Social Anxiety Scale as a self-report instrument: A preliminary psychometric analysis. Behaviour Research and Therapy, 40, 701-715.
4. Baldwin, D., Bobes, J., Stein, D. J., Scharwächter, I., & Faure, M. (1999). Paroxetine in social phobia/social anxiety disorder: A randomized, double-blind, placebo-controlled trial. British Journal of Psychiatry, 175, 120-126.
5. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893-897.
6. Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford Press.
7. Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corporation.
8. Black, B., Uhde, T. W., & Tancer, M. E. (1992). Fluoxetine for the treatment of social phobia. Journal of Clinical Psychopharmacology, 12, 293-295.
9. Blomhoff, S., Haug, T. T., Hellström, K., Holme, I., Humble, M., Madsbu, H. P., et al. (2001). Randomized controlled general practice trial of sertraline, exposure therapy and combined treatment in generalized social phobia. British Journal of Psychiatry, 179, 23-30.
10. Brown, T. A., Di Nardo, P. A., & Barlow, D. H. (1994). Anxiety Disorders Interview Schedule for DSM-IV. Albany, NY: Graywind Publications.
11. Chambless, D. L., & Hope, D. A. (1996). Cognitive approaches to the psychopathology and treatment of social phobia. In P. M. Salkovskis (Ed.), Frontiers of cognitive therapy (pp. 345-382). New York: Guilford Press.
12. Clark, D. M. (1997). Cognitive therapy for social phobia: Some notes for therapists. Unpublished manuscript.
13. Clark, D. M. (2001). A cognitive perspective on social phobia. In W. R. Crozier & L. E. Alden (Eds.), International handbook of social anxiety (pp. 405-430). Chichester, UK: Wiley.
14. Clark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P., & Gelder, M. G. (1994). A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. British Journal of Psychiatry, 164, 759-769.
15. Clark, D. M., Salkovskis, P. M., Hackmann, A., Wells, A., Ludgate, J., & Gelder, M. (1999). Brief cognitive therapy for panic disorder: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 67, 583-589.
16. Clark, D. M., & Wells, A. (1995). A cognitive model of social phobia. In R. Heimberg, M. Liebowitz, D. A. Hope, & F. R. Schneier (Eds.), Social phobia: Diagnosis, assessment and treatment (pp. 69-93). New York: Guilford Press.
17. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
18. Committee on Safety of Medicines. (1988). Benzodiazepines, dependence and withdrawal symptoms. Current Problems, 21, 1-2.
19. Fedoroff, I. C., & Taylor, S. (2001). Psychological and pharmacological treatments of social phobia: A meta-analysis. Journal of Clinical Psychopharmacology, 21, 311-324.
20. Feske, U., & Chambless, D. L. (1995). Cognitive-behavioral versus exposure only treatment for social phobia: A meta-analysis. Behavior Therapy, 26, 695-720.
21. First, B., M., Gibbon, M., Spitzer, R. L., Williams, J. B. W., & Benjamin, L. S. (1997). User's guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders: SCID-II. Washington, DC: American Psychiatric Press.
22. First, B. M., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1995). User's guide for the Structured Clinical Interview for DSM-IV Axis I Disorders: SCID-I Clinician Version. Washington, DC: American Psychiatric Press.
23. Fresco, D. M., Erwin, B. A., Heimberg, R. G., & Turk, C. L. (2000). Social phobia and specific phobias. In M. G. Gelder, J. Lopez-Ibor, & N. C. Andreasen (Eds.), New Oxford textbook of psychiatry (pp. 794-807). Oxford, UK: Oxford University Press.
24. Gelernter, C. S., Uhde, T. W., Cimbolic, P., Amkoff, D. B., Vittone, B. J., Tancer, M. E., & Bartko, J. J. (1991). Cognitive-behavioral and pharmacological treatments of social phobia: A controlled study. Archives of General Psychiatry, 48, 938-945.
25. Gould, R. A., Buckminster, S., Pollack, M. H., Otto, M. W., & Yap, L. (1997). Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. Clinical Psychological Science Practice, 4, 291-306.
26. Harvey, A. G., Clark, D. M., Ehlers, A., & Rapee, R. M. (2000). Social anxiety and self-impression: Cognitive preparation enhances the beneficial effects of video feedback following a stressful social task. Behaviour Research and Therapy, 38, 1183-1192.
27. Heckelman, L. R., & Schneier, F. R. (1995). Diagnostic issues. In R. Heimberg, M. Liebowitz, D. A. Hope, & F. R. Schneier (Eds.), Social phobia: Diagnosis, assessment and treatment (pp. 2-20). New York: Guilford Press.
28. Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., et al. (1998). Cognitive-behavioral group therapy vs. phenelzine therapy for social phobia. Archives of General Psychiatry, 55, 1133-1141.
29. Heimberg, R. G., Salzman, D. G., Holt, C. S., & Blendell, K. A. (1993). Cognitive-behavioral group treatment for social phobia: Effectiveness at 5-year follow-up. Cognitive Therapy and Research. 14, 1-23.
30. Hollon, S. D., De Rubeis, R. J., Evans, M. D., Wierner, M. J., Garvey, M. J., Grove, W. M., et al. (1992). Cognitive therapy and pharmacotherapy for depression: Singly and in combination. Archives of General Psychiatry, 49, 774-781.
31. Hood, S. D., & Nutt, D. J. (2001). Psychopharmacological treatments: An overview. In W. R. Crozier & L. E. Alden (Eds.), International handbook of social anxiety (pp. 471-504). Chichester, UK: Wiley.
32. Hope, D., Herbert, J., & White, C. (1995). Diagnostic subtype, avoidant personality disorder, and efficacy of cognitive-behavioral group therapy for social phobia. Cognitive Therapy and Research, 19, 399-417.
33. Huppert, J. D., Roth, D. A., Keefe, F. J., Davidson, J. R. T., & Foa, E. B. (2002, November). Comprehensive CBT, fluoxetine, and their combination: A randomized, placebo controlled trial. Paper presented at the 36th Annual Convention of the Association for Advancement of Behavior Therapy, Reno, Nevada.
34. Kobak, K. A., Greist, J. H., Jefferson, J. W., & Katzelnick, D. J. (2002). Fluoxetine in social phobia: A double-blind, placebo-controlled pilot study. Journal of Clinical Psychopharmacology, 22, 257-262.
35. Koponen, H., Lepola, U., & Juhani, L. E. V. (1995, March). Fluoxetine in social phobia: A pilot study. Paper presented at the 15th National Conference of the Anxiety Disorders Association of America, Pittsburgh, PA.
36. Leonard, B. E. (1996). The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals. In J. P. Feighner & W. F. Boyer (Eds.), Selective serotonin re-uptake inhibitors (2nd ed., pp. 35-62). Chichester, UK: Wiley.
37. Liebowitz, M. R. (1987). Social phobia. Modern problems in Pharmacopsychiatry, 22, 141-173.
38. Liebowitz, M. R., Heimberg, R. G., Schneier, F. R., Hope, D. A., Davies, S., Holt, C. S., et al. (1999). Cognitive-behavioral group therapy versus phenelzine in social phobia: Long-term outcome. Depression and Anxiety, 10, 89-98.
39. Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A. J., et al. (1992). Phenelzine vs. atenolol in social phobia: A placebo-controlled comparison. Archives of General Psychiatry, 49, 290-300.
40. Magee, W. J., Eaton, W. W., Wittchen, H-U., Gonagle, K. A., & Kessler, R. C. (1996). Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Archives of General Psychiatry, 53, 159-168.
41. Marks, I., & Mathews, A. M. (1979). Brief standard self-rating for phobic patients. Behaviour Research and Therapy, 17, 263-267.
42. Mattick, R. P., & Clarke, J. C. (1998). Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behaviour Research and Therapy, 36, 455-470.
43. Mattick, R. P., & Peters, L. (1988). Treatment of severe social phobia: Effects of guided exposure with and without cognitive restructuring. Journal of Consulting and Clinical Psychology, 56, 251-260.
44. Morgan, H., & Raffles, C. (1999). Does reducing safety behaviours improve treatment response in patients with social phobia? Australian and New Zealand Journal of Psychiatry, 33, 503-510.
45. Perugi, G., Nassini, S., Lenzi, M. Simonini, E., Cassano, G. B., & McNair, D. M. (1994). Treatment of social phobia with fluoxetine. Anxiety, 1, 282-286.
46. Rapee, R. M. (1995). Descriptive psychopathology of social phobia. In R. Heimberg, M. Liebowitz, D. A. Hope, & F. R. Schneier (Eds.), Social phobia: Diagnosis, assessment and treatment (pp. 41-69). New York: Guilford Press.
47. Rapee, R. M., & Heimberg, R. G. (1997). A cognitive-behavioral model of anxiety in social phobia. Behaviour Research & Therapy, 35, 741-756.
48. Rogers, J. L., Howard, K. I., & Vessey, J. T. (1993). Using significance tests to evaluate equivalence between two experimental groups. Psychological Bulletin, 113, 553-565.
49. Rosenthal, R., & Rosnow, R. L. (1991). Essentials of behavioral research: Methods and data analysis (2nd ed.). New York: McGraw-Hill.
50. Salaberria, K., & Echeburua, E. (1998). Long-term outcome of cognitive therapy's contribution to self-exposure in vivo to the treatment of generalized social phobia. Behavior Modification, 22, 262-284.
51. Schneier, F. R., Chin, S. J., Hollander, E., & Liebowitz, M. R. (1992). Fluoxetine in social phobia. Journal of Clinical Psychopharmacology, 12, 62-64.
52. Scholing, A., & Emmelkamp, P. M. G. (1993). Exposure with and without cognitive therapy for generalized social phobia: Effects of individual and group treatment. Behaviour Research and Therapy, 31, 667-681.
53. Stahl, S. M. (1998). Not so selective serotonin inhibitors. Journal of Clinical Psychiatry, 59, 343-344.
54. Stein, M. B., Fyer, A. J., Davidson, J. R. T., Pollack, M. H., & Wiita, B. (1999). Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study. American Journal of Psychiatry, 156, 756-760.
55. Stein, M. B., Liebowitz, M. R., Lydiard, B., Pitts, C. D., Bushnell, W., & Gergel, I. (1998). Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial. JAMA, 280, 708-713.
56. Taylor, S. (1996). Meta-analysis of cognitive-behavioral treatments for social phobia. Journal of Behavior Therapy and Experimental Psychiatry, 27, 1-9.
57. Van Ameringen, M., Lane, R. M., Bowen, R. C., Chokka, P. R., Goldner, E. M., Johnston, D. G., et al. (2001). Sertraline treatment of generalized social phobia: A 20 week, double-blind, placebo-controlled study. American Journal of Psychiatry, 158, 275-281.
58. Van Ameringen, M., Mancini, C., & Streiner, D. L. (1993). Fluoxetine efficacy in social phobia. Journal of Clinical Psychiatry, 54, 27-31.
59. Van Ameringen, M., Swinson, R. P., Walker, J. R., & Lane, R. M. (1999). A placebo-controlled study of sertraline in generalized social phobia. Journal of the European College of Neuropsychopharmacology, 9(Suppl.), 235.
60. Versiani, M., Nardi, A. E., Mundim, F. D., Alves, A. B., Liebowitz, M. R., & Amrein, R. (1992). Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine. British Journal of Psychiatry, 161, 353-360.
61. Watson, D., & Friend, R. (1969). Measurement of social-evaluative anxiety. Journal of Consulting and Clinical Psychology, 33, 448-457.
62. Wells, A. (1997). Cognitive therapy of anxiety disorders: A practice manual and conceptual guide. Chichester, UK: Wiley.
63. Wells, A., Clark, D. M., Salkovskis, P. M., Ludgate, J., Hackmann, A., & Gelder, M. (1995). Social phobia: The role of in-situation safety behaviors in maintaining anxiety and negative beliefs. Behavior Therapy, 26, 153-161.
64. Wells, A., & Papageorgiou, C. (1998). Social phobia: Effects of external attention on anxiety, negative beliefs, and perspective taking. Behavior Therapy, 29, 357-370.